SETH LEDERMAN - Chief Executive Officer, Director at Tonix Pharmaceuticals Holding Corp.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
TNXP on Nasdaq
All Insider Reports
All Insider Reports

SETH LEDERMAN - trading volume in the past year for Tonix Pharmaceuticals Holding Corp.

Holdings reported by SETH LEDERMAN for Tonix Pharmaceuticals Holding Corp.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.001 par value 4,005 $86,307 $21.55 15 May 2025 Direct
Common Stock, $0.001 par value 1 $0 $0.1521 15 May 2025 By IRA Account
Common Stock, $0.001 par value 1 $0 $0.1521 15 May 2025 Lederman & Co.
Stock Option 123,958 25 Feb 2025 Direct Common Stock

Transactions reported by SETH LEDERMAN for Tonix Pharmaceuticals Holding Corp.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.